Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Rob who wrote (1182)	2/10/1999 8:57:00 PM
From: David Culver	Respond to of 1501

Rob Your point is well taken at some point i will take some profits and let the rest ride. should still get some price appreciation when we start phase 1. dave

To: Rob who wrote (1182)	2/11/1999 11:44:00 AM
From: Ron Kertesz	Read Replies (1) \| Respond to of 1501

I am just a cautious person by nature. I do think this is a good deal for Inflazyme. I also felt that the news release didn't tell the story clearly enough for the layperson so that's why I posted what I learned. I have the benefit of having worked in the industry for years and I have negotiated these types of deals with big pharma. Even some of the people in the industry that I work with read the news release and weren't clear as to whether this was an option deal,or a full license. I felt that greater clarity in the exact nature of this agreement should be posted. So I guess what I'm saying is that I like the deal Inflazyme signed, I didn't like their press release. Ron